Faculty Digital Archive

Archive@NYU >
NET Institute >
NET Institute Working Papers Series >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2451/28384

Title: Quantifying Equilibrium Network Externalities in the ACH Banking Industry
Authors: Ackerberg, Daniel A. - University of Arizona and NBER
Gowrisankaran, Gautam - Washington University in St. Louis and NBER
Issue Date: 1-Jan-2003
Series/Report no.: NET Institute Working Paper;03-06
Abstract: We seek to estimate the causes and magnitudes of network externalities for the automated clearinghouse (ACH) electronic payments system, using a panel data set on individual bank usage of ACH. We construct an equilibrium model of consumer and bank adoption of ACH in the presence of a network. The model identifies network externalities from correlations of changes in usage levels for banks within a network, from changes in usage following changes in market concentration or sizes of competitors and from adoption decisions of banks outside the network with small branches in the network, and can separately identify consumer and bank network effects. We structurally estimate the parameters of the model by matching equilibrium behavior to the data, using simulated maximum likelihood and a data set of localized networks, and use a bootstrap to recover confidence intervals. The parameters are estimated with high precision and fit various moments of the data reasonably well. We find that most of the impediment to ACH adoption is due to large consumer fixed costs of adoption. The deadweight loss from the network externality is moderate: the optimal number of ACH transactions is about 16% higher than the equilibrium level.
URI: http://hdl.handle.net/2451/28384
Appears in Collections:NET Institute Working Papers Series

Files in This Item:

File Description SizeFormat
Gowrisankaran_03-06.pdf252.54 kBAdobe PDFView/Open

Items in Faculty Digital Archive are protected by copyright, with all rights reserved, unless otherwise indicated.

 

The contents of the FDA may be subject to copyright, be offered under a Creative Commons license, or be in the public domain.
Please check items for rights statements. For information about NYU’s copyright policy, see http://www.nyu.edu/footer/copyright-and-fair-use.html 
Valid XHTML 1.0 | CSS